In-Depth Vitamin D Therapy Market Report: Business Trends, Growth Factors, and Forecast to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Vitamin D Therapy Industry?
The value of the vitamin D therapy market has experienced swift expansion in recent years. It is projected to increase from $2.92 billion in 2024 to $3.24 billion in 2025, undergoing a compound annual growth rate (CAGR) of 11.1%. The surge during the historic period can be linked to the heightened awareness about vitamin D deficiency, rise in bone-related health conditions, an increasing elderly population and prevalence of osteoporosis, insights from scientific studies underscoring its advantages, the escalation in diseases linked to lifestyle habits, and endorsements from the medical community for supplementation.
In the next few years, we can anticipate a swift growth in the Vitamin D therapy market. The projected expansion will see the market scale to “$5.33 billion by 2029, with a compound annual growth rate (CAGR) of 13.2%. This anticipated expansion in the forecasted period is due to the consistent education and awareness efforts, an increasing aged population, the use of vitamin D in managing chronic conditions, advancements in formulation technology, worldwide health measures, and a growing emphasis on personalized nutrition. The forecast period is expected to witness trends such as the broadening of applications beyond bone health, governmental incentives for supplementation, innovations in formulation and delivery methods, attention on clinical research and evidence-backed practices, and expansion of the global market.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp
What Forces Are Driving The Growth Of The Vitamin D Therapy Industry?
The anticipated rise in malnutrition instances is likely to accelerate the expansion of the vitamin D therapy market. In terms of nutrient consumption, malnutrition encompasses nutrient deficiencies, overabundance, inequities, or improper nutrient absorption. Vitamin D insufficiency is widespread among malnourished inpatients and related to higher long-term fatality rates, especially when patients are not undergoing vitamin D therapy. Thus, a growth in malnutrition incidents incites a requirement for vitamin D treatment. For instance, the World Health Organization, a Switzerland-based organization striving to enhance health, safeguard the global community, and assist the vulnerable, stated in March 2024 that in 2022, approximately 390 million adults over the age of 18 worldwide were underweight, with 2.5 billion overweight, which includes 890 million who were obese. In the age group of 5-19-year-olds, there were 390 million overweight children and adolescents, with 160 million of them being obese. Additionally, 190 million were extremely thin. Nearly 149 million children under five were stunted, while 37 million were overweight or obese. Almost half of the mortalities among children under five are associated with undernutrition. Therefore, the rising occurrences of malnutrition are propelling the growth of the vitamin D therapy market.
What Is The Overview Of Market Segmentation In The Vitamin D Therapy Industry?
The vitamin d therapy market covered in this report is segmented –
1) By Administration: Oral, Parenteral
2) By Purchasing: OTC Drugs, Prescription Drugs
3) By Age Group: Children, Adults, Senior Adults
4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders
Subsegments:
1) By Oral: Vitamin D3 Supplements (Cholecalciferol), Vitamin D2 Supplements (Ergocalciferol), Vitamin D Fortified Foods And Beverages
2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol), Injectable Vitamin D2 (Ergocalciferol), Intravenous Vitamin D Preparations
What Long-Term Trends Are Likely To Affect The Vitamin D Therapy Market?
The surge of product innovations is a key trend currently being observed in the vitamin D therapy market. A number of prominent companies in the sector are venturing into the development of fresh and innovative products to maintain their market standing. An example of this occurred in February 2024 when Cadila Pharmaceuticals Pvt Ltd., a multinational pharmaceutical enterprise based in India, unveiled its groundbreaking Aqueous Cholecalciferol Injection – the company’s first aqueous formulation. This product has set a new standard in treating Vitamin D deficiency, offering a swift and efficient solution. The outstanding pharmacokinetics (PK) and pharmacodynamics (PD) exhibited by this unique formula assert its superiority over traditional oil-based cholecalciferol preparations in the market.
Who Are The Primary Players Operating Across The Global Vitamin D Therapy Market?
Major companies operating in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report
Which Region Offers The Most Growth Potential For The Vitamin D Therapy Market Through 2029?
North America was the largest region in the vitamin D therapy market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin D therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=8810&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
